Lexicon Pharmaceuticals
LXRX
LXRX
123 hedge funds and large institutions have $626M invested in Lexicon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 47 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $657M → $626M (-$31.1M)
Holders
123
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$136M | |
| 2 | +$27.2M | |
| 3 | +$9.97M | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$7.28M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$4.55M |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$164K | |
| 3 | -$100K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$91.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$88.1K |